These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29621613)

  • 1. Cytokine targeting in rheumatoid arthritis.
    Bui VL; Brahn E
    Clin Immunol; 2019 Sep; 206():3-8. PubMed ID: 29621613
    [No Abstract]   [Full Text] [Related]  

  • 2. Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.
    Drosos AA
    Drugs; 2002; 62(6):891-907. PubMed ID: 11929337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of immunopathogenesis in rheumatoid arthritis].
    Zorin NA; Zorina VN; Zorina RM; Trofimenko NA; Gorbatovskiĭ IaA
    Ter Arkh; 2005; 77(12):88-91. PubMed ID: 16514829
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.
    Venkatesha SH; Dudics S; Acharya B; Moudgil KD
    Int J Mol Sci; 2014 Dec; 16(1):887-906. PubMed ID: 25561237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine networks--towards new therapies for rheumatoid arthritis.
    McInnes IB; Liew FY
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cytokines to treat autoimmunity.
    Kyttaris VC
    Clin Immunol; 2019 Sep; 206():108251. PubMed ID: 31445171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
    Dupuis ML; Conti F; Maselli A; Pagano MT; Ruggieri A; Anticoli S; Fragale A; Gabriele L; Gagliardi MC; Sanchez M; Ceccarelli F; Alessandri C; Valesini G; Ortona E; Pierdominici M
    Front Immunol; 2018; 9():1903. PubMed ID: 30174672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A.
    Ayer LM; Issekutz AC; Waterhouse CC; Stadnyk AW
    Inflammation; 2000 Oct; 24(5):447-61. PubMed ID: 10921508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform.
    Chikanza IC
    Ann N Y Acad Sci; 2002 Jun; 966():39-48. PubMed ID: 12114257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine?
    Miossec P
    Joint Bone Spine; 2004 Mar; 71(2):87-90. PubMed ID: 15050191
    [No Abstract]   [Full Text] [Related]  

  • 12. Selected cytokine pathways in rheumatoid arthritis.
    Noack M; Miossec P
    Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.
    Cook AD; Visvanathan K
    Expert Opin Ther Targets; 2004 Oct; 8(5):375-90. PubMed ID: 15469389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
    Feldmann M; Brennan FM; Williams RO; Elliott MJ; Maini RN
    J Inflamm; 1995-1996; 47(1-2):90-6. PubMed ID: 8913935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine pathways and joint inflammation in rheumatoid arthritis.
    Choy EH; Panayi GS
    N Engl J Med; 2001 Mar; 344(12):907-16. PubMed ID: 11259725
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients.
    Miyake S; Yagita H; Maruyama T; Hashimoto H; Miyasaka N; Okumura K
    J Exp Med; 1993 Mar; 177(3):863-8. PubMed ID: 7679713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Cytokine antagonists].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(5):201-3. PubMed ID: 12557112
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of new drugs for the treatment of rheumatoid arthritis].
    Mizushima Y
    Nihon Rinsho; 1992 Mar; 50(3):526-30. PubMed ID: 1588742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular therapeutic targets in rheumatoid arthritis.
    Sacre SM; Andreakos E; Taylor P; Feldmann M; Foxwell BM
    Expert Rev Mol Med; 2005 Aug; 7(16):1-20. PubMed ID: 16117838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic pathogenetic mechanism of rheumatoid arthritis and its therapeutic significance].
    Binzus G; Dettmer N; Josenhans G; Tillmann K
    Z Rheumaforsch; 1972; 31(3):137-52. PubMed ID: 5027030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.